Literature DB >> 20015950

Human papillomavirus-associated oropharyngeal cancer: a new clinical entity.

N P Nguyen1, A Chi, L M Nguyen, B H Ly, U Karlsson, V Vinh-Hung.   

Abstract

The incidence of oropharyngeal cancers is rising worldwide in both nonsmokers and nondrinkers. Epidemiology studies suggest a strong association between human papillomavirus (HPV) 16 infection, changing sexual behavior and cancer development. Despite initial presentation with locally advanced disease and poorly differentiated histology, HPV-associated oropharyngeal carcinoma is associated with a good prognosis because its response to chemotherapy and radiation. Clinicians should be aware of the risk of oropharyngeal cancer in young people to avoid unnecessary delay in diagnosis and treatment. A history of oral sex should be elicited in young patients with enlarged neck nodes and/or tonsillar masses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015950     DOI: 10.1093/qjmed/hcp176

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  12 in total

1.  Treatment trends in head and neck cancer: Surveillance, Epidemiology, and End Results (SEER) Patterns of Care analysis.

Authors:  Jennifer A Schlichting; Nitin A Pagedar; Catherine Chioreso; Charles F Lynch; Mary E Charlton
Journal:  Cancer Causes Control       Date:  2019-05-22       Impact factor: 2.506

Review 2.  [HPV-associated oropharyngeal carcinoma. Status quo and relationship with cancer of unknown primary].

Authors:  M Mollenhauer; G Assmann; P Zengel; O Guntinas-Lichius; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

3.  The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.

Authors:  Jan Laco; Hana Vosmikova; Vendula Novakova; Petr Celakovsky; Helena Dolezalova; Lubos Tucek; Jana Nekvindova; Milan Vosmik; Eva Cermakova; Ales Ryska
Journal:  Virchows Arch       Date:  2011-01-11       Impact factor: 4.064

Review 4.  Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma.

Authors:  Christopher Schutt; Klaus Bumm; Leonardo Mirandola; Giovanni Bernardini; Nicholas D' Cunha; Lukman Tijani; Diane Nguyen; Joehassin Cordero; Marjorie R Jenkins; Everardo Cobos; W Martin Kast; Maurizio Chiriva-Internati
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

5.  Strategies for non-resectable head and neck cancer.

Authors:  Nerina Denaro; Elvio G Russi; Marco C Merlano
Journal:  Curr Treat Options Oncol       Date:  2013-12

6.  Cancer of unknown primary originating from oropharyngeal carcinomas are strongly correlated to HPV positivity.

Authors:  Pamela Zengel; Gerald Assmann; Martin Mollenhauer; Andreas Jung; Karl Sotlar; Thomas Kirchner; Stephan Ihrler
Journal:  Virchows Arch       Date:  2012-08-02       Impact factor: 4.064

7.  Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer.

Authors:  Anbarasu Kannan; Kate L Hertweck; Julie V Philley; Robert B Wells; Santanu Dasgupta
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

8.  Feasibility of tomotherapy-based image-guided radiotherapy for locally advanced oropharyngeal cancer.

Authors:  Nam P Nguyen; Misty Ceizyk; Paul Vos; Michael Betz; Alexander Chi; Fabio Almeida; Rick Davis; Benjamin Slane; Steven Gelumbauskas; Lexie Smith-Raymond; Dave Abraham; Michelle Stevie; Siyoung Jang; Vincent Vinh-Hung
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

Review 9.  Oral cancer, HPV infection and evidence of sexual transmission.

Authors:  Fátima Martín-Hernán; Juan-Gabriel Sánchez-Hernández; Jorge Cano; Julián Campo; Jorge del Romero
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-05-01

Review 10.  Oral sex and oropharyngeal cancer: The role of the primary care physicians.

Authors:  Nam P Nguyen; Ly M Nguyen; Sroka Thomas; Bevan Hong-Ly; Alexander Chi; Paul Vos; Ulf Karlsson; Vincent Vinh-Hung
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.